Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)613-615
Number of pages3
JournalSurgical infections
Issue number7
StatePublished - Sep 1 2022

Bibliographical note

Funding Information:
Susan Kline is part of a CME course faculty discussing immune-modulating drugs in COVID-19 therapy supported by Lilly and has National Institutes of Health grants for COVID-related clinical research, the Adaptive COVID Treatment Trial, and the Novavax COVID-19 vaccine trial. The remaining authors have no disclosures or conflicts of interest to report.

Cite this